Capillary electrophoresis application in the analysis of the anti-cancer drugs impurities

Acta Poloniae Pharmaceutica - Drug Research

Volumn 70, Issue 2, 2013, Pages 171-180

  Zalewska, Marta ^a   Wilk, Karol ^b   Milnerowicz, Halina ^a,c  

^a Department of Biomedical and Environmental Analysis ^*  (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c UNIVERSITY SCHOOL OF PHYSICAL EDUCATION   (Poland)

Author keywords

Anti Cancer Drugs; Capillary Electrophoresis

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; GALLIUM; KP 46; LOBAPLATIN; METHOTREXATE; PACLITAXEL; PLATINUM COMPLEX; TAMOXIFEN; UNCLASSIFIED DRUG;

CAPILLARY ELECTROCHROMATOGRAPHY; CAPILLARY ELECTROPHORESIS; CAPILLARY ISOELECTRIC FOCUSING; CAPILLARY ZONE ELECTROPHORESIS; DRUG CONTAMINATION; DRUG IMPURITY; DRUG PURITY; ELECTROOSMOSIS; ELECTROPHORETIC MOBILITY; GEL ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOTACHOPHORESIS; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; MICROEMULSION ELECTROKINETIC CHROMATOGRAPHY; NONAQUEOUS CAPILLARY ELECTROPHORESIS; REVIEW; THIN LAYER CHROMATOGRAPHY;

ANTINEOPLASTIC AGENTS; DRUG CONTAMINATION; DRUG STABILITY; ELECTROPHORESIS, CAPILLARY; QUALITY CONTROL;

EID: 84876704292     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Gorog S.: Trends Anal. Chem. 25, 755 (2006).
2. Humfrey C.D.: Toxicol. Sci. 100, 24 (2007).
3. Handzlik J., Spengler G., Mastek B., Dela A., Molnar J., Amaral L., Kieć-Kononowicz K.: Acta Pol. Pharm. Drug Res. 69, 149 (2012).
4. Jorgenson J.W., Lukacs K.D.: Anal. Chem. 59, 1298 (1981).
5. Morzunova T.G.: Pharm. Chem. J., 40, 158 (2006).
6. Hilhorst M.J., Somsen G.W.: Electrophoresis, 22 2542 (2001).
7. Altria K.D., Elder D.: J. Chromatogr. A 1023 1 (2004).
8. Altria K.D.: J. Chromatogr. A 735, 43 (1996).
9. Mallampati, S., Pauwels, J., Hoogmartens, J., Van Schepdael, A.: CE in impurity profiling of drugs. in Capillary electrophoresis methods for pharmaceutical analysis, Ahuja S., Jimidar I. Eds., Chapt. 12, pp. 259-315, Elsevier, Academic Press, Amsterdam 2008.
10. Altria K., Marsh A., Sänger-van de Griend C.: Electrophoresis 27, 2263 (2006).
11. Suntornsuk L.: Anal. Bioanal. Chem. 398, 29 (2010).
12. Veuthey J.-L.: Anal. Bioanal. Chem, 38, 93 (2005).
13. Geiser L., Veuthey J.-L.: Electrophoresis, 28, 45 (2007).
14. ICH Harmonised Tripartite Guideline-Impurities in new drug substances Q3A (R2) (2006).
15. ICH Harmonised Tripartite Guideline-Impurities in new drug products Q3B (R2) (2006).
16. Polish Pharmacopoeia, VIII edn., Polish Pharmaceutical Society, Warszawa 2008.
17. Hartinger Ch.G., Keppler B.K.: Electrophoresis 28, 3436 (2007).
18. Verschraagen M., van der Born K., Zwiers T.H., van der Vijgh W.J.: J. Chromatogr. B 772, 273 (2002).
19. Wenclawiak B.W., Wollman M.: J. Chromatogr. A 724, 317 (1996).
20. Michalke B.: J. Trace Elem. Med. Biol. 24, 69 (2010).
21. Gotti R., Andrisano V.: Electrophoresis 25, 2830 (2004).
22. Pujol M., Girona V., Prat J., Munoz M., De Bolos J.: Int. J. Pharm. 146, 263 (1997).
23. Li X.-F., Carter S. J., Dovichi N. J. : J. Chromatogr. A 895, 81 (2000).
24. Rao K.V.: Pharm. Res. 10, 521 (1993).
25. Shao L.K, Locke D.C.: Anal. Chem. 70, 897 (1998).
26. Shakalisava Y., Regan F.: Electrophoresis., 30, 3110 (2009).
27. Chitambar C.R.: Curr. Opin. Oncol. 16, 547 (2004).
28. Foteeva L.S., Stolyarova N.V., Timerbaev A.R., Keppler B.K.: J. Pharm. Biomed. Anal. 48, 218 (2008).
29. Hommerson P., Khan A.M.: Rapid Commun. Mass Spectrom., 23 2878 (2009).
30. Holzgrabe U., Brinz D., Kopec S., Weber C., Bitar Y.: Electrophoresis. 27, 2283 (2006).